| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Zenas BioPharma, Inc.
13G/A
ZBIO · 98937L105
|
1.5% |
11/5/2026
Event 9/30/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.